RHI Magnesita raises Vesuvius approach

RHI Magnesita raises Vesuvius approach

RHI Magnesita has raised its pursuit of Vesuvius materially again. The latest cash-and-share proposal values each Vesuvius share at an implied 549p and has conditional backing from its largest shareholder.


RHI Magnesita is in advanced talks over a possible cash-and-share acquisition of Vesuvius after raising its proposal to an implied value of 549p per share.

Vesuvius, the London-listed specialist in molten-metal flow engineering and related industrial technologies, has received a series of approaches from refractory-products group RHI Magnesita since September 2025.

The latest proposal would give Vesuvius shareholders 470p in cash plus approximately 0.028 new RHI Magnesita shares for every share they hold. Based on RHI Magnesita’s closing share price immediately before the latest announcement, the combination produced a headline value of 549p per Vesuvius share.

Shareholders on Vesuvius’s register at the relevant record date would also retain the company’s 7.1p interim dividend due for payment in October. The proposal represents a substantial premium to the Vesuvius share price before the offer period began.

If a transaction proceeds on the current terms, Vesuvius investors would receive around 7.1 million new RHI Magnesita shares in aggregate and own approximately 13% of the enlarged group. RHI Magnesita intends to finance the cash element through new debt facilities.

The approach has conditional backing from Vesuvius’s largest shareholder. Cevian Capital, which controls approximately 23% of Vesuvius’s issued ordinary share capital excluding treasury shares, has given an irrevocable undertaking supporting a recommended transaction on the announced terms.

The mix of cash and shares leaves Vesuvius investors with continuing exposure to the combined company rather than crystallising the entire value of their holding at completion. That structure can help bridge valuation differences, but it also makes part of the consideration dependent on movements in RHI Magnesita’s own share price.

The industrial logic centres on businesses serving steelmaking, foundries, and other high-temperature manufacturing operations. Vesuvius provides flow-control engineering, consumables, and technologies used in molten-metal processes, while RHI Magnesita supplies refractory products engineered to withstand extreme heat.

Both therefore operate close to global heavy-industry customers whose investment and production levels can move with steel demand, construction, automotive output, and wider manufacturing cycles. Scale can spread research, manufacturing, sales, and administrative costs across a broader customer base, while potentially strengthening purchasing and geographic coverage.

A combination would nevertheless create a substantial integration project. The groups operate across multiple countries and specialised product lines, meaning management would have to address regulatory approvals, customer relationships, production footprints, technology portfolios, and overlapping corporate functions.

Competition scrutiny may also extend beyond the UK because industrial customers frequently source highly specialised products across international markets. Any regulatory assessment would depend on the degree of overlap within individual refractory, flow-control, and related product categories rather than the headline size of the combined company alone.

The proposal remains preliminary. RHI Magnesita’s announcement was made under the UK Takeover Code and does not constitute a firm offer. Discussions between the boards are continuing, and the bidder has said there is no certainty that an offer will ultimately be made.

That leaves valuation and board support as the immediate variables. The latest terms combine a higher cash component, continued equity exposure, and retention of the interim dividend. Whether that is sufficient to produce a recommended transaction will determine whether the talks progress into a formal takeover process.

—



  • Insolvency Service moves intervention earlier

    Insolvency Service moves intervention earlier

    The Insolvency Service is shifting intervention earlier in financial distress. Its five-year strategy combines earlier guidance, faster recovery, stronger data sharing, and expanded action against abusive phoenix companies.


  • RHI Magnesita raises Vesuvius approach

    RHI Magnesita raises Vesuvius approach

    RHI Magnesita has raised its pursuit of Vesuvius materially again. The latest cash-and-share proposal values each Vesuvius share at an implied 549p and has conditional backing from its largest shareholder.


  • AstraZeneca invests bn in Summit

    AstraZeneca invests $2bn in Summit

    AstraZeneca is investing heavily to deepen its oncology combination strategy. The $2bn Summit Therapeutics stake accompanies clinical work combining ivonescimab with AstraZeneca antibody-drug conjugates across cancer types.